chr7-100107382-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_139315.3(TAF6):c.1898C>T(p.Ser633Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000258 in 1,592,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. S633S) has been classified as Benign.
Frequency
Consequence
NM_139315.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TAF6 | NM_139315.3 | c.1898C>T | p.Ser633Leu | missense_variant | 15/15 | ENST00000453269.7 | |
AP4M1 | NM_004722.4 | c.*500G>A | 3_prime_UTR_variant | 15/15 | ENST00000359593.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TAF6 | ENST00000453269.7 | c.1898C>T | p.Ser633Leu | missense_variant | 15/15 | 1 | NM_139315.3 | P1 | |
AP4M1 | ENST00000359593.9 | c.*500G>A | 3_prime_UTR_variant | 15/15 | 1 | NM_004722.4 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152238Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000378 AC: 9AN: 237924Hom.: 0 AF XY: 0.0000389 AC XY: 5AN XY: 128566
GnomAD4 exome AF: 0.0000222 AC: 32AN: 1439952Hom.: 0 Cov.: 34 AF XY: 0.0000238 AC XY: 17AN XY: 713438
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74378
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2022 | TAF6: PM2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 30, 2023 | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 633 of the TAF6 protein (p.Ser633Leu). This variant is present in population databases (rs776521741, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with TAF6-related conditions. ClinVar contains an entry for this variant (Variation ID: 2246163). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.2009C>T (p.S670L) alteration is located in exon 15 (coding exon 15) of the TAF6 gene. This alteration results from a C to T substitution at nucleotide position 2009, causing the serine (S) at amino acid position 670 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at